Inequitable Conduct Claim
Cubist Case Shanghai'd? Teva Launches Tricky New Strategy
By Randy Osborne
Monday, June 21, 2010
Last week's twist in the patent fight between Cubist Pharmaceuticals Inc. and Teva Pharmaceutical Industries Ltd. brought renewed attention to the worth of the case advanced by the latter, but it's not clear how the outcome of the battle would affect the ultimate fate of Cubist, which some bankers say is all but assured a takeover, and the only question is price.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.